The growing global prevalence of diabetes has emerged as a major factor spurring the demand for the Glycated Albumin Assay Market size due to the need for advanced diagnostic tools for optimal glycemic management. Glycated albumin assays are gaining traction due to their advantage over HbA1c tests in assessing short-term glycemic variations. Major players are focusing on geographical expansion strategies across high potential emerging markets to leverage the rising healthcare expenditure on diabetes management. Increasing availability of glycated albumin assays across healthcare settings is supporting the global expansion of the market.

Get More Insights On Glycated Albumin Assay

https://www.insightprobing...